Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society
The uptake of recent guidelines on cardiovascular optimisation is good, but access to cardiology investigations and consultations, and auto-segmentation, represent barriers to modifying radiotherapy practices in lung cancer to reduce the risk of radiation cardiotoxicity.
Authors
- Joshua D. Mitchell (ORCID: https://orcid.org/0000-0001-7371-5742)
- Mark Harbinson (ORCID: https://orcid.org/0000-0003-2186-4943)
- Gerard Walls (ORCID: https://orcid.org/0000-0003-0845-9732)
- Gerard G. Hanna (ORCID: https://orcid.org/0000-0003-1003-5138)
- Alex Lyon
Institutions
- Belfast Health and Social Care Trust (GB)
- University of Ulster (GB)
- Washington University in St. Louis (US)
- Belfast City Hospital (GB)
- Royal Brompton Hospital (GB)
- The Northern Ireland Cancer Centre (GB)
Publication Details
- Journal
- Clinical Oncology
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1016/j.clon.2024.09.001
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Cancer Research UK